AI-Augmented RBQM: Validated Algorithms Deliver Double-Digit Reductions in Risk-Review Cycle Times
Discover how AI is transforming Risk-Based Quality Management at SCOPE 2025 Barcelona
Cyntegrity is excited to join SCOPE 2025 in Barcelona, where we’ll present the latest breakthroughs in AI-powered Risk-Based Quality Management (RBQM) for clinical trials. As the industry aligns with ICH E6(R3) and ICH E8(R1), the need for data-driven Quality by Design and real-time oversight is more critical than ever.
Don’t miss our real-life examples, validation guardrails, and expert strategies.
📍 Visit us at Booth #4
📅 14 October 2025 – 15 October 2025
In our featured session, Artem Andrianov, Cyntegrity’s CEO, will present how our GxP-validated AI:
- Auto-classifies Critical to Quality (CTQ) factors
- Calibrates KRI/QTL thresholds with historical benchmarks
- Identifies protocol deviations in near real time
This approach has reduced RBQM review cycle times by a median of 30–35%, giving teams more time to focus on root-cause analysis and prevention. You’ll also gain insights into:
- Defining Critical Data and Processes using AI
- Setting reliable KRI/QTL thresholds
- Ensuring inspection-ready RBQM with scalable methods
- Current AI limitations—and how to overcome them
Don’t miss this chance to learn how AI-driven RBQM can streamline your processes, improve compliance, and enhance overall study quality. Visit us at Booth #4 to connect with our experts and explore innovative solutions shaping the future of clinical trials.
